[ 68Ga]Ga-DO3A-S02-GCG

N/A

Report date: 2025/11/24 17:31:52

NME

Base Information

Drug Name[ 68Ga]Ga-DO3A-S02-GCG

Drug Alias Name[ 68 Ga]Ga-DO3A-S02-GCG[68Ga]Ga-DO3A-S02-GCG

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[5]

Mechanisms of ActionGlucagon receptor agonistsPositron-emission tomography enhancers

TargetsGlucagon receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSanofi-Aventis Deutschland Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesSanofi-Aventis Deutschland Gmbh

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A